Trials / Recruiting
RecruitingNCT06556693
Janus II Feasibility
Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Zoll Medical Corporation · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dual Channel Stimulation | implant of dual channel stimulation device |
Timeline
- Start date
- 2025-08-12
- Primary completion
- 2028-04-01
- Completion
- 2034-12-01
- First posted
- 2024-08-16
- Last updated
- 2025-10-29
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06556693. Inclusion in this directory is not an endorsement.